Diethyl 2-methyl-2-[(1R)-4-methyl-5-oxocyclohex-3-en-1-yl]cyclopropane-1,1-dicarboxylate
C17H24O5 — CID 162405014
Data last refreshed: (MolForge compound catalog, from PubChem)
About Diethyl 2-methyl-2-[(1R)-4-methyl-5-oxocyclohex-3-en-1-yl]cyclopropane-1,1-dicarboxylate
Diethyl 2-methyl-2-[(1R)-4-methyl-5-oxocyclohex-3-en-1-yl]cyclopropane-1,1-dicarboxylate (PubChem CID 162405014) has the molecular formula C17H24O5 and a molecular weight of 308.37 g/mol. Its IUPAC name is diethyl 2-methyl-2-[(1R)-4-methyl-5-oxocyclohex-3-en-1-yl]cyclopropane-1,1-dicarboxylate.
Molecular Properties
| Compound Name | Diethyl 2-methyl-2-[(1R)-4-methyl-5-oxocyclohex-3-en-1-yl]cyclopropane-1,1-dicarboxylate |
|---|---|
| PubChem CID | 162405014 |
| Molecular Formula | C17H24O5 |
| Molecular Weight | 308.37 g/mol |
| Exact Mass | 308.16 |
| IUPAC Name | diethyl 2-methyl-2-[(1R)-4-methyl-5-oxocyclohex-3-en-1-yl]cyclopropane-1,1-dicarboxylate |
| SMILES | CCOC(=O)C1(C(=O)OCC)CC1(C)[C@@H]1CC=C(C)C(=O)C1 |
| InChI | InChI=1S/C17H24O5/c1-5-21-14(19)17(15(20)22-6-2)10-16(17,4)12-8-7-11(3)13(18)9-12/h7,12H,5-6,8-10H2,1-4H3/t12-,16?/m1/s1 |
| InChIKey | PTAGPPMFFISTJM-ZGTOLYCTSA-N |
| XLogP | 2.43 |
| TPSA | 69.67 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 308.37 |
| LogP ≤ 5 | 2.43 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162405014 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.